Pharma giant refused costs in HSE tender case
Because of its interest in the outcome, the pharmaceutical giant was joined as a notice party to a Commercial Court action brought by Sanofi against the HSE’s awarding of a tender for the six-in-one vaccine last January
Glaxosmithkline has been refused most of its costs following a legal row in which it said the “safety and efficacy” of one of its vaccines was being challenged by a global rival.
Because of its interest in the outcome, the pharmaceutical giant was joined as a notice party to a Commercial Court action brought by Sanofi against the HSE’s awarding of a tender for the six-in-one vaccine last January.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Some people with cystic fibrosis still awaiting Covid-19 vaccine, charity warns
Cystic Fibrosis Ireland expresses concern about younger patients who are at very high risk from the coronavirus but still have not received their jab
Top medic: ‘If the state can pay for Viagra, it can pay for extreme pregnancy sickness drugs’
Peter Boylan, a former master of the National Maternity Hospital, says hyperemesis gravidarum is a severe condition and it‘s reasonable to expect the drugs payment scheme to reimburse sufferers
Over 300 administered vaccine doses not recorded as given to priority groups
HSE says failure to record cohort of vaccine recipient may be due to poor record keeping or a technical issue
Praxis Care to hire 400 new carers as demand for services grows
The charity, which supports people with mental health problems and learning difficulties, is open to recruiting from hospitality sector as training will be provided